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Introduction: The aim of our study is to identify the contribution of hematopoietic-derived cells to burn-wound
healing in a non-severe injury. There are many conflicting reports of the contribution of bone marrow-derived cells
to wound healing and whether these are hematopoietic or mesenchymal in origin. The role of hematopoietic
lineage cells is investigated in this study in the context of the response to burn injury.
Methods: Transgenic mice expressing the LacZ reporter gene in all cells of the hematopoietic lineage underwent a
non-severe full-thickness burn injury (8 % of total body surface area). Wounds were assessed for LacZ-positive cells
at days 7, 14, and 28 post-injury by using whole-mount staining. Cells were also cultured from the wounds at each
time point and analysed for expression of fibroblast and myofibroblast markers.
Results: At day 7, positive cells were identified in the wounds representing the inflammatory response. Some
dermal cells were also identified at this early stage. At day 14, positive cells were also identified and were cultured
from the wound tissue samples. However, by day 28, no positive cells could be detected or cultured from the
healed wound tissue. Isolated LacZ-positive cells did not express collagen 1 or α-smooth muscle actin proteins,
indicating that they had not differentiated into dermal fibroblast-type cells.
Conclusions: In this model of burn injury, hematopoietic lineage cells were present in the healing wound only
transiently and did not appear to contribute to the long-term scar population. This is in contrast with reports
demonstrating that fibrocytes contribute a long-term sustained population in scar tissue. This work demonstrates
that in a non-severe burn injury model there is a sustained transient contribution of hematopoietic cells to the
healed wound. Further characterisation of the types and extent of wounding required to establish a long-term
hematopoietic response will be important in determining future cell-based therapies.Introduction
Many reports support an important role of bone
marrow-derived cells, including fibrocytes, in the post-
inflammatory phase of wound repair [1]. Fibrocytes have
been implicated in the healing process in diverse tissues,
including liver, lung, and skin, and an array of roles have
been attributed to these cells in long-term repaired tis-
sue such as hypertrophic scar [2]. Fibrocytes are thought
to be cells of hematopoietic origin, differentiating into
mesenchymal cell types as they migrate into sites of* Correspondence: mark.fear@uwa.edu.au
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article, unless otherwise stated.injury [3]. However, others have shown no long-term
contribution of cells of bone marrow origin in healed
wounds [4, 5]. Therefore, whilst the evidence supporting
a key transient role in wound healing for fibrocytes is
substantial, the issue of whether cells of hematopoietic
lineage have a long-term role in healed tissue is not clear
[6]. Here, we have used the Vav-Cre transgenic mouse
model to monitor the fate of cells of hematopoietic
lineage after moderate burn injury. C57BL/6 J Vav-Cre
transgenic mice, which express Cre recombinase under
the control of the Vav promoter, restricting expression
to all hematopoietic lineage cells and endothelial line-
ages [7, 8], were crossed with the ROSA26R-LacZ
reporter strain [9]. Offspring were genotyped, and re-
combinant mice expressing LacZ restricted to thes distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
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thickness burn injury (as previously described [10]).
Methods
Ethical approval
All animal experiments were carried out with approval
by the relevant institutional animal ethics committees
(Murdoch University, Perth, Australia, approval #R2080/
07; Royal Perth Hospital animal ethics committee ap-
proval #R13/07), and all experiments were conducted
in accordance with the National Health and Medical
Research Council’s Australian Code of Practice for the
Care and Use of Animals for Scientific Purposes.
Genotyping
For parental genotyping, tail-tip genomic DNA was pre-
pared [11]. Cre-positive animals were genotyped by
using polymerase chain reaction primers and conditions
as previously described [7]. ROSA26LacZ animals were
genotyped by using primers and conditions previously
described [9].
Recombinant Vav-CreRosa26LAcZ offspring to be
used for burn injury experiments underwent a pre-injury
full-thickness 3-mm punch biopsy. This biopsy was
taken at the site of the burn injury and immediately
prior to the injury. Biopsies underwent whole-mount
staining for LacZ (described below) and were sectioned
and analysed. Those animals with detectable LacZ in cir-
culating and endothelial cells only were assessed post-
injury. Other animals either with no detectable expression
or with expression not restricted to the hematopoietic and
endothelial lineage (chimeric mice) were euthanased prior
to analysis [8].
Mouse burn injury and sample preparation
The murine burn wound model is a contact thermal
full-thickness injury on the dorsum of the mice and is
approximately 8 % of total body surface area [10]. At
days 7, 14, 21, and 28 post-injury, control animal groups
were euthanased (n = 5 per group per time point). The
entire wound, including adjacent 3-mm skin margins,
was excised. The wound was bisected along the cranial
caudal axis. One half of the sample was processed for
whole-mount LacZ staining, and the second half of the
sample was prepared for cell isolation and culture.
LacZ whole-mount staining and histology
Tissue was washed three times for 20 min at room
temperature and incubated overnight at 37 °C in the
dark in LacZ staining buffer: 2 mM MgCl2, 5 mM
K3Fe(CN)6, 5 mM K4Fe(CN)6, 5-bromo-4-chloro-3-indolyl-
β-D-galactopyranoside (X-gal) 1 mg/ml in phosphate-
buffered saline (PBS). Samples were then washed three
times in 3 % dimethyl sulfoxide/PBS for 10 min, fixed in4 % paraformaldehyde, and paraffin-embedded. Tissue sec-
tions (5 μm) were deparaffinised, stained in Eosin stain for
45 sec, and imaged under a light microscope. For counting
LacZ-positive dermal cells at day 14, three areas of
0.1 mm2 in each section were assessed for positive and
negative dermal cells (excluding hair follicles and endothe-
lial cells). Two sections were counted for each wound for a
total of five animals (10 sections, three areas per section).
Cell isolation and characterisation
Tissue was dispersed into a single cell suspension as pre-
viously described [10]. The single cell suspension was
then washed thoroughly before being plated in T25-cm2
tissue culture flasks in Dulbecco’s minimum essential
medium/F12 Glutamax supplemented with 10 % fetal
bovine serum, 0.5 μg/ml Fungizone antimycotic liquid,
100 μg/ml kanamycin, 100 U/ml penicillin, and 100 μg/ml
streptomycin (Invitrogen, Carlsbad, CA, USA) and incu-
bated at 37 °C in 5 % CO2. After 24 h, the cells were
washed with PBS (pH7.4), and fresh media minus Fungi-
zone and kanamycin was added to the cells. Once the flask
was confluent, cells were seeded onto round coverslips fit-
ted into six-well plates before being fixed in glutaralde-
hyde (diluted 1:100 PBS pH 7.4) and stained by using a
LacZ staining solution (2 mM MgCl2, 5 mM K3Fe(CN)6,
5 mM K4Fe(CN)6, X-gal 1 mg/ml in PBS) overnight at
37 °C in a dark chamber.
Characterisation of LacZ-positive cultured cells
Isolated cells underwent further characterisation by
staining for fibroblast markers in addition to LacZ. Im-
munofluorescence was conducted by using a rabbit anti-
collagen I antibody (Abcam, Cambridge, MA, USA) to
stain for collagen type 1-producing fibroblasts and rabbit
anti-α-smooth muscle actin antibody (Abcam) for myofi-
broblasts. Secondary antibody goat anti-rabbit IgG Alexa
Fluor 488 (Molecular Probes, Eugene, OR, USA) was
used. Slides were viewed by using a fluorescence micro-
scope at the Centre for Microscopy, Characterization
and Analysis at the University of Western Australia.
Results
Whole wound tissue was isolated and stained for the ex-
pression of LacZ post-injury. At day 7 post-injury, there
is a substantial inflammatory infiltrate both in the der-
mal layer and in the loose connective tissue below the
panniculus carnosus (Fig. 1a, b). At day 14 post-injury,
there is positive staining for LacZ in cells within the der-
mal compartment (Fig. 1c, d). These cells appear in the
circulation and as inflammatory cells, but cells can also
be observed in the dermis and they appear to have the
distinct fibroblast spindle shape (Fig. 1d, inset). There is
a high degree of variation within the wound as to the
percentage of LacZ-positive cells are in the dermis with
Fig. 1 LacZ-positive cells are detected in the wound up to day 14 after moderate burn injury. LacZ-positive cells are present in the wound at day
7 (a, b) and day 14 (c, d). At day 7, substantial inflammatory infiltrate in the skin and loose connective tissue below the panniculus carnosus (a, b)
are observed. By day 14, positive cells remain and some cells in the dermal layer are positive for LacZ. (c) Inset shows percentage of positive LacZ
dermal cells at day 14 ± standard deviation. d Inset shows higher magnification of LacZ-positive dermal cells. At day 21 (e) and day 28 (f), LacZ-
positive cells other than endothelial or immune cells are not detected. At day 14, 14 % ± 4.1 % of interfollicular dermal cells appear to be positive
for LacZ (c). Arrows indicate LacZ-positive cells
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being LacZ-positive at day 14 (mean ± standard devi-
ation, Fig. 1c inset). At days 21 and 28 post-injury, no
LacZ-positive cells were detected in the interfollicular
skin (Fig. 1e, f, respectively). Positive expression at days
21 and 28 consisted solely of hematopoietic cells and
blood vessels consistent with the normal expression of
Vav-Cre recombinant mice.
Tissue samples were also used to isolate dermal cells.
Interestingly, whilst LacZ-positive cells were isolated
from day 14 tissue samples, no lacZ-positive cells were
isolated from day 21 or day 28 samples (data not shown).
LacZ-positive cells have fibroblast-like morphology(Fig. 1d). However, they do not appear to express either
collagen I (Fig. 2a-d) or α-smooth muscle actin (α-
SMA) (Fig. 2e-h). This strongly suggests that they are
not of a true fibroblast phenotype.
Discussion
The data clearly show a transient population of
hematopoietic cells within the healing wound. This ap-
pears to be predominantly during the acute inflamma-
tory phase, and a small number of cells persist longer in
the healing dermis. Immunohistochemistry suggests
that these cells are not of a normal fibroblast phenotype.
Therefore, it is more likely that they represent a residual
Fig. 2 Isolated LacZ-positive cells do not express collagen I or α-SMA. Cells isolated at day 14 were stained for LacZ and collagen I (a-d) or α-SMA
(e-h). Positive cells identified for LacZ expression (a, c) do not stain for collagen I expression (b, d). Other isolated cells not positive for LacZ
expression are collagen I-positive (b, d). Positive cells identified for LacZ expression (e, g) do not stain for α-SMA expression (f, h). Other isolated
cells not positive for LacZ expression are α-SMA-positive (f, h). α-SMA alpha-smooth muscle actin
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monocytes differentiating into macrophages which are
removed at a later point in healing.
From this study, we conclude that there is no long-
term contribution to healed skin tissue of hematopoietic
lineage cells. The use of this transgenic model allows
tracking of cell fate irrespectively of subsequent differen-
tiation. Other reports have suggested that the differenti-
ation of hematopoietic lineage cells, once in the wound,
changes the markers expressed (for example, loss ofCD45 expression) and this masks their continued pres-
ence [12, 13]. However, this study shows clearly that no
cells of hematopoietic lineage persist in this model of
injury.
This model used an injury of approximately 8 % of total
body surface area. In a similar small injury model using
parabiotic mice, an early response of circulating cells was
identified in the wound, and no long-term contribution
was observed [5]. However, the circulating cells were iden-
tified as expressing fibroblast or myofibroblast markers,
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7 post-injury, suggesting that by day 14, similar to our ob-
servations, there was unlikely to be expression of these
markers.
Both of these studies used small injury models, and it
is possible that, in injuries of greater extent, trans-
differentiation and long-term persistence of hematopoietic
cells occur. However, this would restrict the contribution
of hematopoietic cells to only severe injuries, contradic-
ting other reports to date [14]. It is also possible that the
murine model does not accurately reflect the human re-
sponse. It has been shown that there are significant differ-
ences in the injury response between these organisms
[15]. However, many other studies have implicated fibro-
cytes in long-term wound repair using a mouse model [1]
and this is unlikely to underpin the lack of hematopoietic
cells observed in this model when compared with some
other studies.
Recently, a biphasic response of fibrocytes to a burn
injury was demonstrated in a porcine model of injury
[16]. This study demonstrated an acute-phase response
followed by the absence of fibrocytes until day 56 post-
injury. Owing to the shorter time frame of sampling, the
possibility that fibrocytes would have been found in later
scar samples cannot be discounted in this study.
In this study, we hypothesise that the resident cells ob-
served in the dermis at day 14 were most likely longer-
lived macrophage-type cells. There is evidence for mac-
rophages or monocyte precursors differentiating into
fibrocytes and fibroblast cells particularly in the context
of wound healing [17, 18]. There is also evidence that
the monocyte-macrophage-fibroblast lineage is closer to
a continuum rather than distinct lineages of cells [13].
However, these cells do not express fibroblast markers,
and so although the morphology suggests that they are
similar to fibroblasts, they are unlikely to be functioning
in the wound in a similar manner. It is possible that
these cells are altered in phenotype during culture and
that this masks the true cell phenotype. However, other
LacZ-negative cells do express typical fibroblast markers,
and fibroblasts are commonly cultured ex vivo without
significant phenotypic changes. Therefore, although it is
unlikely that the LacZ-positive cells are fibroblastic in
origin, changes to their phenotype in culture cannot be
ruled out. This is also an important consideration for
further characterisation studies. Further characterisation
of these cells will be important to better understand any
potential role in healing.
Conclusions
This study demonstrates only a transient population of
hematopoietic lineage cells present in healing after non-
severe burn injury in this mouse model. The use of this
well-characterised transgenic model circumvents many ofthe limitations of other studies with respect to the influ-
ence of cell differentiation, cell characterisation, and
phenotype assessment on the interpretation of results. It
will be important to use this model to assess other injury
extents (e.g., severe burn injury) and modalities to deter-
mine whether the response is uniform across injury eti-
ology and severity. In light of the recent study showing a
biphasic response, it will also be important to extend the
time frame of these experiments to assess for a possible re-
influx of hematopoietic-derived cells. Finally, it will be crit-
ical to characterise the phenotype of the cells identified and
to fully assess the role played in the healing wound. A more
complete understanding of the origin and role of different
cell types in wound responses will ultimately be critical to
the future of successful cell-based therapies in the field.
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